Results
25
25 companies
Predictive Oncology
Market Cap: US$7.3m
A knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies.
POAI
US$1.11
7D
-0.9%
1Y
-58.4%
Cosmo Pharmaceuticals
Market Cap: US$906.6m
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
CMOP.F
US$65.80
7D
-10.5%
1Y
-10.1%
Nano-X Imaging
Market Cap: US$347.0m
Develops a commercial-grade tomographic imaging device with a digital X-ray source.
NNOX
US$6.05
7D
6.3%
1Y
-36.1%
Spectral AI
Market Cap: US$32.4m
An artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States.
MDAI
US$1.70
7D
9.7%
1Y
-27.4%
Evaxion Biotech
Market Cap: US$11.9m
A clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies.
EVAX
US$1.89
7D
6.2%
1Y
-87.6%
Acarix
Market Cap: US$276.6m
A medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out.
ACIX.F
US$0.03
7D
8.9%
1Y
13.4%
Healwell AI
Market Cap: US$304.1m
A healthcare technology company, focuses on AI and data science for preventative care.
HWAI.F
US$1.14
7D
13.2%
1Y
63.0%
ImmunoPrecise Antibodies
Market Cap: US$20.4m
A biotechnology company that leverages multi-omics modeling and artificial intelligence through a series proprietary and patented technologies.
IPA
US$0.42
7D
10.0%
1Y
-73.0%
Simulations Plus
Market Cap: US$495.9m
Develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.
SLP
US$25.56
7D
-2.0%
1Y
-40.5%
Lantheus Holdings
Market Cap: US$6.8b
Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.
LNTH
US$97.71
7D
-3.4%
1Y
65.6%
iCAD
Market Cap: US$55.1m
Engages in the provision of cancer detection and therapy solutions in the United States.
ICAD
US$2.23
7D
-2.6%
1Y
39.4%
RadNet
Market Cap: US$3.7b
Provides outpatient diagnostic imaging services in the United States and internationally.
RDNT
US$49.25
7D
5.8%
1Y
2.5%
Tempus AI
Market Cap: US$8.3b
Operates as a healthcare technology company.
TEM
US$51.35
7D
8.9%
1Y
n/a
CareCloud
Market Cap: US$66.9m
A healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States.
CCLD
US$1.51
7D
2.7%
1Y
31.3%
Guerbet
Market Cap: US$204.5m
Engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions.
GUER.F
US$22.25
7D
0%
1Y
n/a
BioXcel Therapeutics
Market Cap: US$7.3m
A commercial-stage biopharmaceutical company, engages in utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology.
BTAI
US$2.33
7D
9.4%
1Y
-94.8%
Premier
Market Cap: US$1.7b
Operates as a healthcare improvement company in the United States.
PINC
US$18.55
7D
2.1%
1Y
-14.7%
Perimeter Medical Imaging AI
Market Cap: US$52.4m
A medical technology company, provides advanced imaging tools that address unmet medical needs.
PYNK.F
US$0.40
7D
11.6%
1Y
-35.8%
Ontrak
Market Cap: US$6.4m
Operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States.
OTRK
US$1.55
7D
7.6%
1Y
-73.6%
CeriBell
Market Cap: US$727.1m
Operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.
CBLL
US$20.42
7D
-2.9%
1Y
n/a
HeartSciences
Market Cap: US$3.1m
A medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility.
HSCS
US$2.91
7D
-0.9%
1Y
-75.8%
OmniAb
Market Cap: US$277.2m
A biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States.
OABI
US$2.53
7D
-23.6%
1Y
-50.7%
BioSig Technologies
Market Cap: US$11.5m
A medical technology company, focuses on deciphering the body’s electrical signals starting with heart rhythms.
BSGM
US$0.55
7D
-11.1%
1Y
1.1%
Absci
Market Cap: US$387.1m
Operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.
ABSI
US$3.01
7D
-4.1%
1Y
-39.2%
Aspira Women's Health
Market Cap: US$1.7m
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States.
AWH
US$0.088
7D
-37.2%
1Y
-97.6%